List of works - Pedro Veliça

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.

scientific article published in November 2017

CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor

scientific article

Correction: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers.

scientific article

Cytotoxic T-cells mediate exercise-induced reductions in tumor growth

scientific article published on 23 October 2020

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

scientific article published on 22 January 2016

Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation

scientific article published on 22 April 2015

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

scientific article

Memory lapses in graft-versus-host disease

scientific article published in September 2011

Modified Hypoxia-Inducible Factor Expression in CD8<sup>+</sup> T Cells Increases Antitumor Efficacy

scientific article published on 18 February 2021

Prostaglandin D2 inhibits C2C12 myogenesis

scientific article

Prostaglandins in muscle regeneration.

scientific article published on 04 December 2008

Redirection to the bone marrow improves T cell persistence and antitumor functions.

scientific article published on 27 February 2018

S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate.

scientific article published on 26 October 2016

Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells

scientific article published on 05 December 2018

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

scientific article

T cell tuning for tumour therapy: Enhancing effector function and memory potential of therapeutic T cells.

scientific article

List of works by Pedro Veliça

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.

CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor

Correction: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers.

Cytotoxic T-cells mediate exercise-induced reductions in tumor growth

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Memory lapses in graft-versus-host disease

Modified Hypoxia-Inducible Factor Expression in CD8<sup>+</sup> T Cells Increases Antitumor Efficacy

Prostaglandin D2 inhibits C2C12 myogenesis

Prostaglandins in muscle regeneration.

Redirection to the bone marrow improves T cell persistence and antitumor functions.

S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate.

Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells

Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate

T cell tuning for tumour therapy: Enhancing effector function and memory potential of therapeutic T cells.